Print

CRC282

A Double-Blind, Placebo-Controlled, Randomised, Dose-Escalation Phase I Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Trial Details:

I Completed
University of Surrey June 01, 2011
P2G12
P2G12 Passive Immunization
United Kingdom 11
NCT01403792
https://clinicaltrials.gov/show/NCT01403792